# TB-500 (thymosin beta 4) for venous ulcers: Phase 2 trial

Source: https://pepvault.app/research/tb-500-guarnera-2010

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [TB-500](https://pepvault.app/research#tb-500)

Randomized trial · people

# TB-500 on venous ulcers: safety comparable to placebo in Phase 2

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

An early human trial found thymosin beta 4 on venous ulcers had safety comparable to placebo, with early signs that the 0.03% dose might speed healing.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 73
- **Published:** 2010
- **Journal:** Ann N Y Acad Sci

## What they tested

The team tested whether thymosin beta 4 put on the skin is safe, well tolerated and helpful for healing venous ulcers, which are long-lasting sores of the lower legs.

## How the study was done

A double-blind, placebo-controlled, dose-escalation Phase 2 trial randomized 73 patients with venous stasis ulcers at European sites in Italy and Poland. Double-blind means neither patients nor staff knew who got the peptide, and placebo is a dummy treatment.

<!--promo-->

PepVault for iPhone

## Taking TB-500? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At every dose tested, the safety of thymosin beta 4 was judged acceptable and similar to placebo. The results pointed to the 0.03% dose as possibly speeding wound healing. About 25% of patients had their wounds close fully within 3 months, mainly when the wounds were of small or medium size, or of mild or moderate severity.

## What it doesn’t show

This was a small, early-stage trial, and its signs of faster healing were preliminary, not a firm result. It tested the peptide applied to the skin of venous ulcers only, so it says nothing about other uses or other ways of giving it.

## The paper

Guarnera et al. The effect of thymosin treatment of venous ulcers. Ann N Y Acad Sci. 2010.

- [PubMed (PMID 20536470)](https://pubmed.ncbi.nlm.nih.gov/20536470/)
- [The paper (DOI 10.1111/j.1749-6632.2010.05490.x)](https://doi.org/10.1111/j.1749-6632.2010.05490.x)

## The compound

- [TB-500: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/tb-500)
- [TB-500 dose guide](https://pepvault.app/lab/dosage/tb-500)

## With this study

### TB-500

- [TB-500: the full reference](https://pepvault.app/peptides/tb-500)
- [TB-500 dose guide](https://pepvault.app/lab/dosage/tb-500)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tb-500-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tb-500-10mg)

### Studies

- [Thymosin beta-4: no overall infarct area cut in 96 STEMI patients](https://pepvault.app/research/thymosin-beta-4-zhang-2025)
- [BPC-157: non-significant tendon gains in rats; TB-500 did better](https://pepvault.app/research/bpc-157-bicer-2026)
- [All 9 studies](https://pepvault.app/research#tb-500)

### Compared with

- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [TB-500 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/tb-500-vs-thymosin-beta-4)
- [TB-500 vs GHK-Cu](https://pepvault.app/peptides/compare/tb-500-vs-ghk-cu)
- [TB-500 vs KPV](https://pepvault.app/peptides/compare/tb-500-vs-kpv)
- [TB-500 vs Ac-SDKP](https://pepvault.app/peptides/compare/tb-500-vs-tb-500-fragment)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## More studies on TB-500

- [Thymosin beta-4: no overall infarct area cut in 96 STEMI patients](https://pepvault.app/research/thymosin-beta-4-zhang-2025) Randomized trial · people · 2025
- [BPC-157: non-significant tendon gains in rats; TB-500 did better](https://pepvault.app/research/bpc-157-bicer-2026) Animal study · rats · 2026
- [Thymosin beta-4 in pregnant mice: longer newborns, more mature organs](https://pepvault.app/research/thymosin-beta-4-faa-2021) Animal study · mice · 2021
- [Thymosin beta-4 raised survival in mice with a coronavirus infection](https://pepvault.app/research/thymosin-beta-4-yu-2021) Animal study · mice · 2021
- [Thymosin beta-4: more liver fibrosis in mice bred to make extra TB4](https://pepvault.app/research/thymosin-beta-4-kim-2017) Animal study · mice · 2017
- [Thymosin beta-4 sped skin wound healing in diabetic and aged mice](https://pepvault.app/research/tb-500-philp-2003) Animal study · mice · 2003
- [Every study on TB-500](https://pepvault.app/research#tb-500)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking TB-500? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking TB-500? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### TB-500

- [TB-500: the full reference](https://pepvault.app/peptides/tb-500)
- [TB-500 dose guide](https://pepvault.app/lab/dosage/tb-500)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tb-500-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tb-500-10mg)

### Studies

- [Thymosin beta-4: no overall infarct area cut in 96 STEMI patients](https://pepvault.app/research/thymosin-beta-4-zhang-2025)
- [BPC-157: non-significant tendon gains in rats; TB-500 did better](https://pepvault.app/research/bpc-157-bicer-2026)
- [All 9 studies](https://pepvault.app/research#tb-500)

### Compared with

- [BPC-157 vs TB-500](https://pepvault.app/peptides/compare/bpc-157-vs-tb-500)
- [TB-500 vs Thymosin Beta-4](https://pepvault.app/peptides/compare/tb-500-vs-thymosin-beta-4)
- [TB-500 vs GHK-Cu](https://pepvault.app/peptides/compare/tb-500-vs-ghk-cu)
- [TB-500 vs KPV](https://pepvault.app/peptides/compare/tb-500-vs-kpv)
- [TB-500 vs Ac-SDKP](https://pepvault.app/peptides/compare/tb-500-vs-tb-500-fragment)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Taking TB-500? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on TB-500](https://pepvault.app/research#tb-500)

## The library

- [TB-500](https://pepvault.app/peptides/tb-500)
- [TB-500 dose guide](https://pepvault.app/lab/dosage/tb-500)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
